4//SEC Filing
Finn John 4
Accession 0001209191-13-025754
CIK 0001356857other
Filed
May 12, 8:00 PM ET
Accepted
May 13, 1:27 PM ET
Size
5.1 KB
Accession
0001209191-13-025754
Insider Transaction Report
Form 4
Finn John
Chief Scientific Officer
Transactions
- Sale
Common Stock
2013-05-10$7.47/sh−3,000$22,425→ 186,860 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 21, 2012
- [F2]The weighted average sales price for the transaction reported was $7.475, and the range of prices were between $7.10 and $7.55. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided
Documents
Issuer
Trius Therapeutics Inc
CIK 0001356857
Entity typeother
Related Parties
1- filerCIK 0001479788
Filing Metadata
- Form type
- 4
- Filed
- May 12, 8:00 PM ET
- Accepted
- May 13, 1:27 PM ET
- Size
- 5.1 KB